Alzheimer's disease: Rapid and slow progression

Journal of the Royal Society Interface

Volumn 9, Issue 66, 2012, Pages 119-126

  Thalhauser, Craig J ^a   Komarova, Natalia L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Genetic algorithm; Longitudinal data analysis; Rate of decline in alzheimer's disease

Indexed keywords

BIOPHYSICS; BIOTECHNOLOGY; GENETIC ALGORITHMS;

ALZHEIMER'S DISEASE; AVERAGE RATE; DATA SETS; DISEASE PROGRESSION; LONGITUDINAL DATA; PATHOPHYSIOLOGICAL; PATHOPHYSIOLOGY; RATE OF DECLINE IN ALZHEIMER'S DISEASE;

NEURODEGENERATIVE DISEASES;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE COURSE; FUNCTIONAL ASSESSMENT STAGING; GENETIC ALGORITHM; HUMAN; ONSET AGE;

EID: 84855421397     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2011.0134     Document Type: Article

References (37)

1. Chui, H. C. 1987 The significance of clinically defined subgroups of Alzheimer's disease. J. Neural Transm. Suppl. 24, 57-68.
2. Mann, U. M., Mohr, E., Gearing, M. & Chase, T. N. 1992 Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J. Neurol. Neurosurg. Psychiatry 55, 956-959. (doi:10.1136/jnnp.55.10.956)
3. Craft, S., Teri, L., Edland, S. D., Kukull, W. A., Schellenberg, G., McCormick, W. C., Bowen, J. D. & Larson, E. B. 1998 Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 51, 149-153. (Pubitemid 28345375)
4. Farrer, L. A., Cupples, L. A., van Duijn, C. M., Connor-Lacke, L., Kiely, D. K. & Growdon, J. H. 1995 Rate of progression of Alzheimer's disease is associated with genetic risk. Arch. Neurol. 52, 918-923.
5. Murphy Jr, G. M., Claassen, J. D., DeVoss, J. J., Pascoe, N., Taylor, J., Tinklenberg, J. R. & Yesavage, J. A. 2001 Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889*1 allele. Neurology 56, 1595-1597. (Pubitemid 32532280)
6. Jack Jr, C. R. et al. 2004 Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62, 591-600. (Pubitemid 38252801)
7. Ridha, B. H., Barnes, J., Bartlett, J. W., Godbolt, A., Pepple, T., Rossor, M. N. & Fox, N. C. 2006 Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 5, 828-834. (doi:10.1016/S1474-4422(06)70550-6)
8. Sluimer, J. D., Vrenken, H., Blankenstein, M. A., Fox, N. C., Scheltens, P., Barkhof, F. & van der Flier, W. M. 2008 Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 70, 1836-1841. (doi:10.1212/01.wnl.0000311446.61861.e3)
9. McEvoy, L. K., Fennema-Notestine, C., Roddey, J. C., Hagler Jr, D. J., Holland, D., Karow, D. S., Pung, C. J., Brewer, J. B. & Dale, A. M. 2009 Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 251, 195-205. (doi:10.1148/radiol.2511080924)
10. Nestor, S. M., Rupsingh, R., Borrie, M., Smith, M., Accomazzi, V., Wells, J. L., Fogarty, J. & Bartha, R. 2008 Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 131, 2443-2454. (doi:10.1093/brain/awn146)
11. Mielke, M. M. et al. 2007 Vascular factors predict rate of progression in Alzheimer disease. Neurology 69, 1850-1858. (doi:10.1212/01.wnl.0000279520. 59792.fe)
12. Prolo, P. et al. 2007 Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression. Bioinformation 1, 363-366.
13. Bhargava, D., Weiner, M. F., Hynan, L. S., Diaz-Arrastia, R. & Lipton, A. M. 2006 Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J. Geriatr. Psychiatry. Neurol. 19, 78-82. (doi:10.1177/0891988706286505)
14. Nagahama, Y., Nabatame, H., Okina, T., Yamauchi, H., Narita, M., Fujimoto, N., Murakami, M., Fukuyama, H. & Matsuda, M. 2003 Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur. Neurol. 50, 1-9. (doi:10.1159/000070851)
15. Doody, R. S., Massman, P. & Dunn, J. K. 2001 A method for estimating progression rates in Alzheimer disease. Arch. Neurol. 58, 449-454. (doi:10.1001/archneur.58.3.449)
16. Capitani, E., Cazzaniga, R., Francescani, A. & Spinnler, H. 2004 Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages? Neurol. Sci. 25, 198-204. (doi:10.1007/s10072-004-0322-4)
17. Reisberg, B. 1988 Functional assessment staging (FAST). Psychopharmacol. Bull. 24, 653-659. (Pubitemid 19054371)
18. Sclan, S. G. & Reisberg, B. 1992 Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality. Int. Psychogeriatr. 4(Suppl. 1), 55-69. (doi:10.1017/S1041610292001157)
19. Fitzmaurice, G. 2009 Longitudinal data analysis. Boca Raton, FL: CRC Press.
20. Molenberghs, G. & Verbeke, G. 2001 A review on linear mixed models for longitudinal data, possibly subject to dropout. Statist. Modell. 1, 235-269. (doi:10.1191/147108201128195)
21. Singer, J. & Willett, J. 2003 Applied longitudinal data analysis: modeling change and event occurrence. Oxford, UK: Oxford University Press.
22. Reisberg, B. et al. 1996 Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study. Int. Psychogeriatr. 8, 291-311. (doi:10.1017/S1041610296002657)
23. Reisberg, B. 1986 Dementia: a systematic approach to identifying reversible causes. Geriatrics 41, 30-46. (Pubitemid 16014042)
24. Fogel, L. 1999 Intelligence through simulated evolution: forty years of evolutionary programming. New York, NY: Wiley.
25. Goldberg, D. E. 1989 Genetic algorithms in search, optimization, and machine learning. Reading, MA: Addison-Wesley.
26. Holland, J. H. 1975 Adaption in natural and artificial systems. Ann Arbor, MI: University of Michigan Press.
27. Mitchell, M. 1998 An introduction to genetic algorithms. Cambridge, MA: MIT Press.
28. Farewell, V. T. 1982 The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 38, 1041-1046. (doi:10.2307/2529885)
29. McLachlan, G. A. P. D. 2000 Finite mixture models.Wiley Series in Probability and Statistics. New York, NY: John Wiley and Sons.
30. Taylor, J. M. 1995 Semi-parametric estimation in failure time mixture models. Biometrics 51, 899-907. (doi:10.2307/2532991)
31. Mann, U. M., Mohr, E. & Chase, T. N. 1989 Rapidly progressive Alzheimer's disease. Lancet 2, 799. (doi:10.1016/S0140-6736(89)90857-X)
32. Marra, C., Silveri, M. C. & Gainotti, G. 2000 Predictors of cognitive decline in the early stage of probable Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 11, 212-218. (doi:10.1159/000017239)
33. Mohr, E., Mann, U. M. & Chase, T. N. 1990 Subgroups in Alzheimer's disease: fact or fiction? Psychiatr. J. Univ. Ott. 15, 203-206.
34. Morris, J. C., Edland, S., Clark, C., Galasko, D., Koss, E., Mohs, R., van Belle, G., Fillenbaum, G. & Heyman, A. 1993 The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43, 2457-2465. (Pubitemid 24004527)
35. Storandt, M., Grant, E. A., Miller, J. P. & Morris, J. C. 2002 Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 59, 1034-1041.
36. Suh, G. H., Ju, Y. S., Yeon, B. K. & Shah, A. 2004 A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline. Int. J. Geriatr. Psychiatry 19, 817-824. (doi:10.1002/gps.1168)
37. Cruchaga, C. et al. 2010 SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet. 6, e1001101. (doi:10.1371/journal.pgen.1001101)